Abarido, Silvestre .
HRN: 21-80-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/19/2025
02/25/2025
IV
1.5g
Bid
Cap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes